M&A
-
Stereotaxis to buy Robocath for up to $45M
The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening Stereotaxis’ position in endovascular surgery, said CEO David Fischel.
By Susan Kelly • April 15, 2026 -
AIP to acquire Avanos Medical in $1.27B go-private deal
Avanos Medical generated $701.2 million last year from sectors where it competes with Boston Scientific, Medtronic and Stryker.
By Nick Paul Taylor • April 15, 2026 -
Stryker to buy Amplitude Vascular Systems
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.
By Elise Reuter • April 13, 2026 -
Hologic hires former Baxter leader José Almeida as CEO
The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.
By Nick Paul Taylor • April 8, 2026 -
Retrieved from Hologic on April 06, 2026
Hologic CEO Steve MacMillan to retire after go-private deal
The $18.3 billion acquisition by Blackstone and TPG is expected to close Tuesday.
By Elise Reuter • April 6, 2026 -
Boston Scientific closes buyout of Valencia Technologies
The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.
By Nick Paul Taylor • April 6, 2026 -
Merit Medical acquires View Point for $140M
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
By Nick Paul Taylor • April 2, 2026 -
Labcorp closes purchase of New York pathology reference lab assets
The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through acquisitions.
By Nick Paul Taylor • March 23, 2026 -
Abbott to close $21B Exact Sciences acquisition Monday
Abbott said it has received all regulatory clearances necessary to buy the cancer screening firm.
By Elise Reuter • March 20, 2026 -
Retrieved from Owen Mumford on March 19, 2026
Embecta to buy Owen Mumford for up to $201M
The planned purchase would allow Embecta to serve patients outside of diabetes care.
By Elise Reuter • March 19, 2026 -
Alcon abandons effort to purchase LENSAR after FTC scrutiny
The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye surgery systems.
By Susan Kelly • March 17, 2026 -
Medtronic to acquire Scientia Vascular for $550M
The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.
By Susan Kelly • March 10, 2026 -
Agilent to buy Biocare Medical for $950M
Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.
By Susan Kelly • March 9, 2026 -
RadNet to acquire radiology AI company Gleamer
The acquisition will expand RadNet’s routine imaging portfolio and presence outside the U.S.
By Nick Paul Taylor • March 3, 2026 -
Intuitive expands in Europe with purchase of distributor operations
The surgical robotics giant closed the deal, valued at about 319 million euros up front, to acquire the businesses in southern Europe.
By Susan Kelly • March 2, 2026 -
Medtech M&A starts off strong in 2026
Abbott closed its $21 billion purchase of Exact Sciences in March, concluding one of the largest medtech deals in recent years.
By Elise Reuter • Updated March 23, 2026 -
Quantum Surgical buys J&J’s NeuWave
Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.
By Susan Kelly • Feb. 25, 2026 -
Guardant buys MetaSight for $59M upfront to acquire blood test tech
MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.
By Nick Paul Taylor • Feb. 23, 2026 -
Federal judge strikes down FTC rule expanding premerger reporting requirements
The regulation required firms to provide more details ahead of mergers, likely chilling dealmaking. The Federal Trade Commission could appeal the ruling.
By Emily Olsen • Feb. 19, 2026 -
Danaher to buy Masimo for $9.9B to boost diagnostics portfolio
Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.
By Susan Kelly • Feb. 17, 2026 -
Labcorp closes takeover of Empire City assets to fuel New York expansion
The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.
By Nick Paul Taylor • Feb. 11, 2026 -
Medtronic to acquire CathWorks for up to $585M
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.
By Elise Reuter • Feb. 3, 2026 -
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.
By Ricky Zipp • Jan. 29, 2026 -
Medtech M&A took off in the second half of 2025: report
Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.
By Elise Reuter • Jan. 28, 2026 -
BD, Waters set completion date for $17.5B biosciences and diagnostics merger
With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
By Nick Paul Taylor • Jan. 28, 2026